BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 3
• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 24
• 25
• 26
• 27
• 28

• 

  Pharm Country

  Are Men “Hardwired” For Violence? Neurobiologist Dr. Debra Niehoff Explains

  February 10, 2014

   · 

  1 min read
• 

  BioCapital

  A Way To Increase Drug R&D Success Rates

  February 10, 2014

   · 

  1 min read
• 

  Seven New Genetic Regions Linked To Type 2 Diabetes, Oxford University Study

  February 10, 2014

   · 

  1 min read
• 

  New Wheelchair Device To Prevent Pressure Sores, University of Toronto Study

  February 10, 2014

   · 

  1 min read
• FDA

  Aegerion Pharmaceuticals, Inc.'s JUXTAPID™ (Lomitapide) Capsules Approved In Canada For The Treatment Of Homozygous Familial Hypercholesterolemia (Hofh)

  February 10, 2014

   · 

  7 min read
• Genetown

  RainDance Technologies Unveils Breakthrough In Somatic Cancer Analysis With Thunderbolts™ Sequencing Panel To Profile Actionable Cancer Mutations For Total Sample Cost As Low As $100

  February 10, 2014

   · 

  1 min read
• Business

  Alliqua, Inc. (Formerly known as HepaLife Technologies Inc.) Appoints Janice M. Smiell, M.D. As its First Chief Medical Officer

  February 10, 2014

   · 

  1 min read
• Drug Development

  e-Therapeutics plc Begins Phase I Study Of Oral Formulation Of Anti-Cancer Compound ETS2101 With Healthy Volunteers

  February 10, 2014

   · 

  1 min read
• Business

  Sensient Technologies Corporation Reports Results For The Quarter And Year Ended December 31, 2013

  February 10, 2014

   · 

  1 min read
• Pharm Country

  Plandai Biotechnology, Inc. Wraps Up $15.3 Million Funding Round

  February 10, 2014

   · 

  3 min read